arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Actinium Pharmaceuticals, Inc.

ATNM

$0.80 ▲ +0.03 (+3.71%) at close

26 Visible periods

23 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Actinium Pharmaceuticals, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $25.0M

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -365.5% ↘

FCF / Share $-0.79 ↗

Trailing P/E —

Price / Book 3.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$90.00K

↑ +11.1% —

Net Income Profit after all expenses

$-33.89M

↑ +11.4% —

FCF / Share Free cash flow per share

$-0.79

↑ +28.1% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -365.5% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.73x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
Revenue Growth YoY (%)	—	—	-92.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1252%)	-10.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-225%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	14.2% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	30.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-33.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-14.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	11.4% Fair ↑ Fair Improving Year-over-year change in net income	21.7% Good ↑ Good Improving Year-over-year change in net income	-47.9% Weak ↓ Weak Declining Year-over-year change in net income	-33.3% Weak ↓ Weak Declining Year-over-year change in net income	-11.5% Weak ↓ Weak Declining Year-over-year change in net income	-1.4% Weak ↓ Weak Declining Year-over-year change in net income	7.4% Fair ↑ Fair Improving Year-over-year change in net income	11.1% Fair ↑ Fair Improving Year-over-year change in net income	-9.4% Weak ↓ Weak Declining Year-over-year change in net income	-15.7% Weak ↑ Weak Improving Year-over-year change in net income	14.8% Fair ↑ Fair Improving Year-over-year change in net income	62.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-695.5% Weak Weak Year-over-year change in net income	-142.7% Weak Weak Year-over-year change in net income	N/M	N/M	38.5% Excellent ↑ Excellent Improving Year-over-year change in net income	0.8% Caution ↑ Caution Improving Year-over-year change in net income	7.2% Fair ↑ Fair Improving Year-over-year change in net income	-32.2% Weak ↓ Weak Declining Year-over-year change in net income	20.1% Good ↑ Good Improving Year-over-year change in net income	-62.4% Weak ↓ Weak Declining Year-over-year change in net income	-10.6% Weak Weak Year-over-year change in net income	37.3% Excellent Excellent Year-over-year change in net income	—	—
FCF Growth YoY (%)	28.1% Excellent Excellent Year-over-year change in free cash flow	38.4% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-55.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
FCF / Net Income (x)	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.25x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	4.68x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
Return on Invested Capital (%)	-365.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-101.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-112.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-308.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-213.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-155.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-117.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-89.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	923.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	3106.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-548.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-261.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	21.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-70.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-54.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-189.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-160.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-146.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-119.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-93.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-297.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-1063.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-137.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-53.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-17368.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	—	-116.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-878%)	-134.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-995%)	-49.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-431%)	-33.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-325%)	-36.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-342%)	—	-268.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1889%)	-194.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1397%)	-135.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1000%)	-95.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-738%)	—	—	—	—	-1.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-112%)	—	-134.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-993%)	-162.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1182%)	—	—	—	-224.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1596%)	190.6% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1170%)	293.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1858%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
Interest Coverage (x)	—	—	—	—	—	-2799.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	-848.92x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-5361.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3155.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-25959.06x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-31.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.23x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-18.75x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4.05x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$-48.00M	$-72.90M	$-76.68M	$-108.91M	$-77.83M	$-63.56M	$-9.25M	$-13.67M	$-17.40M	$-20.52M	$-25.64M	$-6.71M	$-5.53M	$-5.62M	$-5.70M	$-150.00	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
Revenue per Share (USD)	$0.00	—	$0.00	$0.04	$0.06	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.09	$-1.27	$-1.83	$-1.37	$-1.20	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.79	$-1.10	$-1.78	$0.34	$-1.02	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.25	$1.05	$1.32	$2.59	$3.32	$3.50	$1.03	$0.08	$0.17	$0.32	$0.50	$-0.06	$-0.06	$0.05	$0.07	$-0.01	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$0.25	$1.05	$1.32	$2.59	$3.32	$3.50	$1.03	$0.08	$0.17	$0.32	$0.50	$-0.06	$-0.06	$0.05	$0.07	$-0.01	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	31.20M	30.07M	26.60M	24.14M	20.57M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
Working Capital (USD)	$41.41M	$66.36M	$69.77M	$100.31M	$72.91M	$60.16M	$4.74M	$8.27M	$13.17M	$17.87M	$21.87M	$-2.08M	$-1.57M	$1.14M	$990.78K	$-35.91K	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$7.83M	$32.76M	$36.38M	$66.48M	$73.55M	$61.32M	$5.64M	$8.81M	$13.67M	$18.01M	$21.97M	$-1.92M	$-1.56M	$1.15M	$992.01K	$-94.62K	$845.16K	$4.16M	$3.46M	$1.82M	$74.28K	$439.12K	$1.57M	$-1.68M	$-1.73M	$1.11M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗	FY 2007 Dec 31, 2007 10-K ↗	FY 2006 Dec 31, 2006 10-K ↗	FY 2005 Dec 31, 2005 10-K ↗	FY 2004 Dec 31, 2004 10-K ↗	FY 2003 Dec 31, 2003 10-K ↗	FY 2002 Dec 31, 2002 10-K ↗	FY 2001 Dec 31, 2001 10-K ↗	FY 2000 Dec 31, 2000 10-K ↗
Sales/Revenue/Turnover (USD)	$90.00K	—	$81.00K	$1.03M	$1.14M	—	—	—	—	—	—	—	—	—	—	$0.00	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$173.00K	$197.00K	$207.00K	$152.00K	$105.00K	$54.00K	$54.00K	$50.72K	$55.94K	$77.52K	$53.47K	$37.91K	$3.26M	$581.00	$633.00	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-33.89M	$-38.24M	$-48.82M	$-33.02M	$-24.77M	$-22.21M	$-21.90M	$-23.65M	$-26.60M	$-24.32M	$-21.03M	$-24.69M	$-66.52M	$-8.36M	$-3.44M	$1.67K	$-3.43M	$-5.57M	$-5.62M	$-6.05M	$-4.58M	$-5.73M	$-3.53M	$-3.19M	$-5.09M	—
Operating Cash Flow (USD)	$-24.58M	$-33.07M	$-47.34M	$8.64M	$-20.87M	$-21.62M	$-21.46M	$-20.57M	$-21.55M	$-20.79M	$-18.54M	$-14.35M	$-50.70M	$-5.21M	$-517.59K	$7.83K	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 26 years · 82 quarters

Actinium Pharmaceuticals, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare ATNM with peers